ASND Ascendis Pharma A/S

73.02
-0.63  -1%
Previous Close 73.65
Open 74.14
Price To Book 8.87
Market Cap 3069214756
Shares 42,032,522
Volume 178,892
Short Ratio
Av. Daily Volume 145,435

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due 1Q 2019.
TransCon hGH
Growth hormone deficiency in children
Phase 2 trial to be initiated 1Q 2019 with top-line data due early 2020.
TransCon
Hypoparathyroidism
Phase 2 trial to be intiated mid-2019.
TransCon CNP
Achondroplasia